Matrix Capital Management Company’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-650,000
| Closed | -$3.33M | – | 7 |
|
|
2024
Q3 | $3.33M | Sell |
650,000
-10,922,590
| -94% | -$55.9M | 0.16% | 7 |
|
|
2024
Q2 | $41.9M | Hold |
11,572,590
| – | – | 0.32% | 19 |
|
|
2024
Q1 | $37.1M | Hold |
11,572,590
| – | – | 0.35% | 20 |
|
|
2023
Q4 | $56.7M | Hold |
11,572,590
| – | – | 0.58% | 14 |
|
|
2023
Q3 | $63.1M | Hold |
11,572,590
| – | – | 0.76% | 14 |
|
|
2023
Q2 | $77.7M | Hold |
11,572,590
| – | – | 0.9% | 13 |
|
|
2023
Q1 | $102M | Hold |
11,572,590
| – | – | 1.39% | 12 |
|
|
2022
Q4 | $88.4M | Hold |
11,572,590
| – | – | 1.69% | 11 |
|
|
2022
Q3 | $82.4M | Hold |
11,572,590
| – | – | 1.58% | 14 |
|
|
2022
Q2 | $93.6M | Hold |
11,572,590
| – | – | 2.12% | 12 |
|
|
2022
Q1 | $161M | Hold |
11,572,590
| – | – | 1.93% | 17 |
|
|
2021
Q4 | $325M | Hold |
11,572,590
| – | – | 3.62% | 14 |
|
|
2021
Q3 | $393M | Sell |
11,572,590
-227,500
| -2% | -$7.73M | 4.48% | 9 |
|
|
2021
Q2 | $482M | Sell |
11,800,090
-509,000
| -4% | -$20.8M | 5.27% | 7 |
|
|
2021
Q1 | $496M | Sell |
12,309,090
-806,000
| -6% | -$32.4M | 5.72% | 7 |
|
|
2020
Q4 | $775M | Hold |
13,115,090
| – | – | 8.39% | 2 |
|
|
2020
Q3 | $638M | Sell |
13,115,090
-2,000,000
| -13% | -$97.3M | 8.48% | 3 |
|
|
2020
Q2 | $731M | Hold |
15,115,090
| – | – | 11.4% | 2 |
|
|
2020
Q1 | $420M | Sell |
15,115,090
-2,217,101
| -13% | -$61.6M | 10.73% | 2 |
|
|
2019
Q4 | $519M | Hold |
17,332,191
| – | – | 11.04% | 3 |
|
|
2019
Q3 | $536M | Hold |
17,332,191
| – | – | 13.21% | 2 |
|
|
2019
Q2 | $837M | Buy |
+17,332,191
| New | +$837M | 15.47% | 1 |
|